Clinical Trial Update: Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 dose-escalation trial of RSLV-132 in subjects with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• RSLV-132

Snippet

Sponsor: Resolve Therapeutics | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED